ClinicalTrials.Veeva

Menu
C

Chiang Mai University | Research Institute for Health Sciences

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-53718678
Rilpivirine
Doravirine

Parent organization

This site is a part of Chiang Mai University

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 5 total trials

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

This is a single-group, open-label, multi-site study in pediatric participants with human immunodeficiency virus type 1 (HIV-1) infection, aged 4 wee...

Enrolling
Human Immunodeficiency Virus (HIV) Infection
Drug: 2 NRTIs
Drug: Doravirine

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Merck Sharp & Dohme (MSD) logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems